Eden Golan may not have won Eurovision, but she has won the hearts of every Israeli, Jew, and music lover with a conscience.

She represented Israel with elegance, courage, and resilience. And that’s what makes her a true winner. 

I feel privileged to have been represented by…

Fresh off the press🎉🎉Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes | Journal of Clinical Oncology ascopubs.org/doi/pdf/10.120…

Embracing Bacterial Consortia in Cancer Immunotherapy: Are We Ready for Clinical Trials? #ascodailynews #immunotherapy #consortia #microbiome #editorial
dailynews.ascopubs.org/do/embracing-b…

Announcing AlphaFold 3: our state-of-the-art AI model for predicting the structure and interactions of all life’s molecules. 🧬

Here’s how we built it with Isomorphic Labs and what it means for biology. 🧵 dpmd.ai/3URDiNo

This is a superb important piece about the distortion and denial of Jewish and Israeli history by Yossi Klein Halevi, author of the great Letters to My Palestinian Neighbor.
After all history is everything in this conflict but it has to be the real history, not an invented one.…

Amazing when someone publishes exactly what you’ve been looking for the past week! As if on cue!
Congrats to the team on what looks like extraordinary work… looking forward to
poring over the many details here.

Excited that our new #openaccess #systematicreview has just been published npj Digital Medicine looking at diagnostic accuracy of #AI in #digitalpathology 💻 🔬

rdcu.be/dGTOD

We got our 6 year old a music player that can log into Apple Music for her birthday… and now she’s Chimerically Speaking’s biggest fan! Very funny to keep hearing the podcast playing in the background 🤣

👉👉👉It’s time to start re-thinking & re-imagining & really discussing a new era of endpoints, response criteria & what it means to achieve #DiseaseModification for patients with #PolycythemiaVera in modern targeted therapy era 📣 #MPNSM

ashpublications.org/blood/article/…

Is there a study of long term DONOR outcomes (presumably sibling easiest to study and presumably older age) in cases of donor cell leukemia? (I feel like I heard Chris Gibson present something along these lines at ASH once?) How many develop their own myeloid neoplasm? CCUS?

wonderful work from Sonia guedan, former post doc. From her lab in Barcelona,j ust published in Nature Communications doi.org/10.1038/s41467…

Wow. I'm pretty sure this really is the greatest honor (or at least greatest convenience?) a university can bestow. Check out the correspondence address:

Saving this little guy for Halloween. #morphologyisdestiny

For your morning commute! Don’t miss our most recent episode.

It is admirable that Palestinian President Abbas said this.
There is much darkness and tragedy.
But this is the future.
2 nations. 2 republics. Israel & Palestine. Security and calmness for both.
There is no other way.

❗️ Very high-yield flow chart right here; In the Bayesian paradigm evidence for an effect comes from the data and from pre-study information, no penalty for answering multiple questions

ht Frank Harrell

hbiostat.org/bayes/bet/mult…

🌟 Innovation never ends ! #CAR #alloHCT

Of 10 patients with relapsed or refractory hematologic cancers who received sequential CAR T-cell infusion followed by allogeneic stem-cell transplantation without GVHD prophylaxis, 6 were alive and disease-free at last follow-up. Read the full article: nej.md/4dqsTQ3